Ownership

Craig Fraser - President and CEO, Director at Windtree Therapeutics Inc /De/

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: WINT on Nasdaq, WINTW on OTC
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Craig Fraser - trading volume in the past year for Windtree Therapeutics Inc /De/

	Shares	%	Avg Price	Total $
Buys	+5K	100%	$0.96	+$4.8K
Sells
Net	+5K	100%		+$4.8K

Holdings reported by Craig Fraser for Windtree Therapeutics Inc /De/

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	57.9K	$59K	$1.02	Sep 27, 2023	Direct
Common Stock	3	$3.06	$1.02	Sep 27, 2023	By Trust
Warrants (Right to Buy)	4.01K			Jul 22, 2024	Direct	Common Stock
Series C Preferred Stock	19			Jul 22, 2024	Direct	Common Stock

Transactions reported by Craig Fraser for Windtree Therapeutics Inc /De/

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.